| abstract |
Disclosed are methods for diagnosis, prognosis, and treatment of muscular dystrophy. Also disclosed is a method for determining efficacy in the treatment of muscular dystrophy. Methods are provided for promoting muscle regeneration, repair, or maintenance in a subject by administering a galectin such as galectin-1 and / or galectin-3 to a subject in need. Also disclosed is a method of enhancing or maintaining muscle strength and / or bone density in a subject by administering an effective amount of a galectin-1 composition, a galectin-3 composition or a combination thereof to a subject in need. Preventing, preventing and / or reducing muscle loss and / or bone loss in a subject by administering to a subject in need thereof an effective amount of a galectin-1 composition, a galectin-3 composition or a combination thereof Each method is disclosed. [Selection] Figure 1 |